Precision health, explained plainly. GLP-1 protocols, peptide science, and sourcing standards — written for people who want to understand what they're putting in their body.
Ozempic costs over $1,000 a month without insurance. Compounded semaglutide can deliver the same active molecule for a fraction of the price — legally, through a physician, from an FDA-registered facility. Here is what you need to know before you decide.
Three tiers of peptide quality. Most providers will not tell you which one they are on.
Next-Gen GLP-1Three receptors, one molecule. Phase 2 trials show up to 24% body weight reduction — the most significant results in the history of metabolic peptide therapy.
PeptidesFrom insulin's discovery to GLP-1 breakthroughs and today's advanced delivery methods — a plain-language guide for people just getting started.
RecoveryFrom obscure research compound to mainstream recovery tool. Here is what the science actually shows about tendon healing, gut repair, and inflammation control.
CultureHealthcare is not collapsing — it is being outpaced. Year 1, Year 5, and Year 10 of the new precision health paradigm.
LongevityNAD+ drops 50% by your 40s. The supplement industry built a $1B+ category on this fact. Here is why delivery method is the variable nobody in the supplement aisle will explain to you.
GLP-1GLP-1 receptor agonists are producing weight loss results once thought to require surgery. Here is exactly how the mechanism works.
GLP-1Two drugs, different mechanisms, different average outcomes. An honest comparison based on clinical trial data.
GLP-1Same molecule — semaglutide — but different approvals, different doses, and different access pathways. Here is what separates them.
GLP-1Nausea is real but manageable. Most people who stop early do so because of poorly managed titration — not because the drug is intolerable.
GLP-1The STEP trials showed 15% average weight loss. Here is what drives the difference between patients and what to realistically expect.
CompoundingThe answer depends entirely on where it comes from. Here is what makes 503B-sourced compounding safe — and what to avoid.
GLP-1Both are tirzepatide. What differs is the approved indication, the dose ceiling, and how insurance covers each product.
GLP-1GLP-1 drugs drive fat loss — but without the right approach, they also drive muscle loss. Here is what the evidence says.
GLP-1Liraglutide was the GLP-1 standard before semaglutide arrived. A generation-by-generation comparison of how outcomes improved.
CompoundingNot all compounding pharmacies operate under the same standard. Here is the difference that determines whether your compound is pharmaceutical-grade.
TelehealthTelehealth access to compounded semaglutide is legitimate — and it requires real clinical oversight. Here is how to evaluate a provider.
GLP-1With multiple GLP-1 drugs available, which produces the best outcomes? A direct answer based on clinical trial data — with honest caveats.
TelehealthA membership is a clinical relationship, not a product subscription. Here is what a well-structured protocol actually includes.
CompoundingSame active molecule, different manufacturer, different device, different price. An honest breakdown of every variable that matters.
GLP-1Tirzepatide compounding access has been one of the most frequently changing areas in GLP-1 therapy. Here is the current landscape.